Merck KGaA (OTCMKTS:MKGAF – Get Free Report) gapped down before the market opened on Tuesday. The stock had previously closed at $159.4510, but opened at $152.6740. Merck KGaA shares last traded at $162.5340, with a volume of 2,695 shares trading hands.
Merck KGaA Price Performance
The firm has a market cap of $21.19 billion, a P/E ratio of 25.03 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The business’s fifty day simple moving average is $161.27 and its 200-day simple moving average is $150.98.
Hedge Funds Weigh In On Merck KGaA
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. MASTERINVEST Kapitalanlage GmbH bought a new position in shares of Merck KGaA in the second quarter worth approximately $4,896,000. Puzo Michael J bought a new stake in Merck KGaA in the second quarter valued at approximately $2,230,000. Somerville Kurt F purchased a new stake in shares of Merck KGaA during the second quarter valued at approximately $1,997,000. Pinnacle Holdings LLC bought a new position in shares of Merck KGaA in the second quarter worth approximately $1,487,000. Finally, North Star Asset Management Inc. purchased a new position in shares of Merck KGaA in the second quarter worth $1,411,000. 0.10% of the stock is currently owned by hedge funds and other institutional investors.
Merck KGaA Company Profile
Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. Merck KGaA is separate from the U.S.-based Merck & Co, Inc, although the two companies share historical roots.
The company operates through three business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, chemicals and bioprocessing technologies used by pharmaceutical, biotechnology and academic customers.
Further Reading
- Five stocks we like better than Merck KGaA
- Cleared for Takeoff: AAR Corp. Expands Its Aerospace Aftermarket Reach
- L3Harris’ $6 Billion THAAD Win Comes at a Crucial Moment for the Stock
- Boeing’s Fighter Victory Opens the Door to Decades of Defense Revenue
- Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
